We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Lawmaker Asks FDA Why Insulin Isn’t Regulated as A Complex Generic
Lawmaker Asks FDA Why Insulin Isn’t Regulated as A Complex Generic
Rep. Mike Kelly (R-Pa.) has asked acting FDA Commissioner Ned Sharpless on why the FDA doesn’t consider insulin to be a complex generic drug — a change that would help boost competion and lower prices.